Get Support – Call 1-888-MITO-411

Fatty Acid Oxidation Disorders

Print Friendly, PDF & Email

What are fatty acid oxidation disorders, and why are they related to mitochondrial disorders?

Additional areas of discussion include:

  • Do patients with mitochondrial defects also have the potential to have fatty acid oxidation defects?
  • How do disorders of metabolism such as FAOD and mitochondrial disease impact the body’s ability to grow, develop and function?
  • What is the current focus in research for understanding and treating FAODs?

Special appreciation to Ultragenyx Pharmaceutical for support of this presentation.

Event Summary Listen Now View Slides

About the Speaker

Dr. Jerry Vockley

Dr. Jerry Vockley

Dr. Vockley received his undergraduate degree at Carnegie-Mellon University in Pittsburgh, Pennsylvania, and received his degree in Medicine and Genetics from the University of Pennsylvania School of Medicine in Philadelphia, Pennsylvania. He completed his pediatric residency at the University of Colorado Health Science Center, and his postdoctoral fellowship in Human Geneticspeer-reviewed and Pediatrics at Yale University School of Medicine in New Haven, Connecticut. Before assuming his current position in Pittsburgh, Dr. Vockley was Chair of Medical Genetics in the Mayo Clinic School of Medicine.

Dr. Vockley is internationally recognized as a leader in the field of inborn errors of metabolism. His current research focuses on mitochondrial energy metabolism, novel therapies for disorders of fatty acid oxidation and amino acid metabolism, and population genetics of the Plain communities in the United States. He has published over 270 peer reviewed scholarly articles, is the principle investigator on four NIH grants and a co-investigator on 7 others. He has an active clinical research program and participates in and consults on multiple gene therapy trials. Dr. Vockley has served on numerous national and international scientific boards including the Advisory Committee (to the Secretary of Health and Human Services) on Heritable Disorders in Newborns and Children where he was chair of the technology committee. He is co-chair of the International Network on Fatty Acid Oxidation Research and Therapy (INFORM). He also serves as chair of the Pennsylvania State Newborn Screening Advisory Committee and the American College of Medical Genetics Therapeutics Committee. He is a past president of the International Organizing Committee for the International Congress on Inborn Errors of Metabolism and the Society for the Inherited Metabolic Disorders (SIMD), and co-founder and editor of the North American Metabolic Academy.

Upcoming
Events

View All
View Calendar

Expert
Series

View All

Upcoming Presentations

View Calendar

Last Presentation

Expert Series: Molecular Bypass Deoxynucleoside Therapy for Thymidine Kinase 2 Deficiency (TK2d)Expert Series:
Presented May 3, 2023

P.O. Box 310
Novi, MI 48376
(888) 648-6228
info@mitoaction.org